Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961)
Status:
Completed
Trial end date:
2006-06-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- to explore the dose-response relation of sugammadex (Org 25969, MK-8616, SCH 900616)
given as a reversal agent at reappearance of T2 after 0.6 mg.kg-1 rocuronium in
pediatric and adult participants
- to explore the pharmacokinetics (PK) of sugammadex in pediatric and adult participants,
and to evaluate the safety of sugammadex in pediatric and adult participants.